Dakota Wealth Management Sells 55 Shares of STERIS plc (NYSE:STE)

Dakota Wealth Management cut its stake in STERIS plc (NYSE:STE) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,146 shares of the medical equipment provider’s stock after selling 55 shares during the quarter. Dakota Wealth Management’s holdings in STERIS were worth $441,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of STE. Geode Capital Management LLC boosted its stake in shares of STERIS by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock worth $556,786,000 after purchasing an additional 17,007 shares during the period. Principal Financial Group Inc. boosted its position in shares of STERIS by 9.5% during the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock valued at $270,230,000 after buying an additional 96,336 shares during the period. Franklin Resources Inc. grew its stake in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after buying an additional 529,308 shares during the last quarter. Raymond James & Associates lifted its stake in shares of STERIS by 1.5% during the 3rd quarter. Raymond James & Associates now owns 801,144 shares of the medical equipment provider’s stock worth $194,309,000 after acquiring an additional 12,005 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of STERIS by 1.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 551,453 shares of the medical equipment provider’s stock worth $133,749,000 after acquiring an additional 6,334 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Activity at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the sale, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on STE. Piper Sandler upgraded STERIS from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Monday, November 18th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, Stephens restated an “overweight” rating and set a $260.00 price objective on shares of STERIS in a report on Thursday, November 7th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $262.50.

STERIS Stock Performance

Shares of NYSE:STE opened at $216.88 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $21.41 billion, a price-to-earnings ratio of 49.52 and a beta of 0.84. The firm has a 50 day moving average of $211.46 and a 200 day moving average of $224.71. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the prior year, the business posted $2.03 EPS. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. On average, sell-side analysts predict that STERIS plc will post 9.11 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Tuesday, November 19th were paid a dividend of $0.57 per share. The ex-dividend date of this dividend was Tuesday, November 19th. This represents a $2.28 annualized dividend and a dividend yield of 1.05%. STERIS’s dividend payout ratio (DPR) is presently 52.05%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.